Bupropion-induced pancytopenia

BMJ Case Rep. 2024 Nov 26;17(11):e262831. doi: 10.1136/bcr-2024-262831.

Abstract

Bupropion is not a well established cause of medication-induced pancytopenia. In this report, we discuss a case of agranulocytosis, normocytic anemia and severe thrombocytopenia, with concurrent drug-induced rash within 3 weeks of bupropion initiation. Bone marrow biopsy demonstrated hypocellularity <10% without dysplastic features or increase in blast cells. Other causes of cytopenias, including infections, nutritional deficiencies, autoimmune disorders, liver/renal disease, thrombotic microangiopathy, primary bone marrow disorders and secondary marrow infiltrative diseases were ruled out. Pancytopenia resolved after 1 week of bupropion discontinuation and supportive care.

Keywords: Drugs: psychiatry; Haematology (drugs and medicines); Mood disorders (including depression); Safety; Unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Agranulocytosis / chemically induced
  • Antidepressive Agents, Second-Generation* / adverse effects
  • Bupropion* / adverse effects
  • Humans
  • Pancytopenia* / chemically induced

Substances

  • Antidepressive Agents, Second-Generation
  • Bupropion